The era of predictable growth for Medicare Advantage plans is fast approaching a significant roadblock, following 2 decades of continually increasing enrollment. By 2026, the program is expected to ...

The FDA will now review Moderna’s seasonal mRNA influenza vaccine application, setting a mid-2026 decision date.

Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...

Systematic review finds sleep disturbances in menopause are highly prevalent and linked to worse QOL, depression, pain, and reduced work productivity.

Emerging HER2-targeted therapies in lung cancer highlight the importance of real-world data and survival metrics for patient outcomes and treatment access.

Pharmacists play a vital role in oncology, enhancing patient care through medication management, education, and support for novel therapies.

This news comes amid a push within value-based care to ensure high-cost medical interventions deliver meaningful improvements ...

A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions.

Patients who required coronary artery bypass grafting (CABG) surgery had worse outcomes when they were living with myasthenia gravis (MG), according to a new study published in BMC Anesthesiology. 1 ...

In the final part of his interview with The American Journal of Managed Care®, Jordan Karlitz, MD, of Exact Sciences, discussed clinical-, behavioral-, and policy-based interventions he believes could ...

Ameet Patel, MD, explains how multiple myeloma treatment settings depend on safety, logistics, and patient needs.

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...